CIAM
MIRA icon

Caitong International Asset Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Caitong International Asset Management’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 2497

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Caitong International Asset Management's MIRA Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in MIRA Pharmaceuticals (MIRA) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2497 among its holdings.

26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Caitong International Asset Management held 1 share of MIRA Pharmaceuticals worth $1 as of Q1 2026.
  • MIRA Pharmaceuticals was a new Caitong International Asset Management position in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2497 holding.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.